NIH Weekly Funding Opportunities and Policy Notices
Notice NOT-HG-20-009 from the NIH Guide for Grants and Contracts
Notice NOT-AA-19-028 from the NIH Guide for Grants and Contracts
Notice NOT-NS-20-008 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-OH-20-001 from the NIH Guide for Grants and Contracts. The purpose of this NOFO is to enhance the quality and complement the availability of health and safety training for mineworkers in the Western United States. As a result, the National Institute for Occupational Safety and Health (NIOSH) invites applications for cooperative agreements to support the development and implementation of training and education programs.
Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)
Funding Opportunity PAR-20-043 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications for P30 Cancer Center Support Grants (CCSGs) to support NCI-designated Cancer Centers. CCSGs support two types of cancer centers: 1) Comprehensive Cancer Centers, which demonstrate reasonable depth and breadth of research activities in each of three major areas: basic laboratory; clinical; and prevention, control and population-based research, and which have substantial transdisciplinary research that bridges these scientific areas; and 2) Cancer Centers, which are primarily focused on basic laboratory; clinical; and prevention, cancer control, and population-based research; or some combination of these areas. The purpose of both types of NCI-designated Cancer Centers is to capitalize on all institutional cancer research capabilities, integrating meritorious programs in laboratory, clinical, and population research into a single transdisciplinary research enterprise across all institutional boundaries. Cancer Centers supported through this FOA are expected to serve as major sources of discovery of the nature of cancer and of development of more effective approaches to prevention, diagnosis, and therapy; to contribute significantly to the development of shared resources that support research; to collaborate and coordinate their research efforts with other NCI-funded programs and investigators; and to disseminate research findings for the benefit of the community.
Notice NOT-AG-20-006 from the NIH Guide for Grants and Contracts
Notice NOT-DA-20-003 from the NIH Guide for Grants and Contracts
Notice NOT-DK-19-028 from the NIH Guide for Grants and Contracts
Notice NOT-DK-20-001 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-CA-20-006 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is associated with the Beau Biden Cancer MoonshotSM Initiative (https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative) that is intended to accelerate cancer research. The purpose of this FOA is to develop, test, and evaluate interventions and implementation approaches, or adapt existing approaches, to improve patient/provider/family risk communication and decision making for individuals and families with an inherited susceptibility to cancer. Specifically, this FOA targets the following area designated as a scientific priority by the Blue Ribbon Panel (https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/blue-ribbon-panel/prevention-screening-working-group-report.pdf) Recommendation G (https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/blue-ribbon-panel#ui-id-3 ): "Sponsor initiatives to improve the current state of early detection, genetic testing, genetic counseling, and knowledge landscape of the mechanisms and biomarkers associated with cancer development and conduct implementation science research to accelerate development, testing, and broader adoption of proven strategies to significantly reduce cancer risk and address cancer health disparities in these areas." This Funding Opportunity Announcement invites U01 applications for projects that develop, test, and evaluate interventions and implementation approaches, or adapt existing approaches, to improve patient/provider/family risk communication and decision making for individuals and families with an inherited susceptibility to cancer so that they can make informed clinical risk management decisions.
Notice NOT-AA-19-030 from the NIH Guide for Grants and Contracts
Notice NOT-AI-20-006 from the NIH Guide for Grants and Contracts
Notice NOT-OD-20-014 from the NIH Guide for Grants and Contracts
Notice NOT-OD-20-011 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-NS-20-007 from the NIH Guide for Grants and Contracts. This FOA invites applications from multidisciplinary teams to perform secondary data analysis, using existing datasets from two or more multi-site clinical research projects, to address scientific and clinical hypotheses relevant to neurological disorders and conditions within the NINDS mission. In this phased funding mechanism, applications are required to systematically and comprehensively perform cross-project data harmonization and curation, assessed using Go/No-go data-quality metrics, prior to funding of the second phase of data analyses. Consistent with the FAIR (findable, accessible, interoperable and reusable) data principles, this funding opportunity expects open-source cataloging of the processes and tools used for harmonization, curation, and analysis, as well as controlled access to the curated datasets.
Notice NOT-AG-20-005 from the NIH Guide for Grants and Contracts
Notice NOT-DK-20-007 from the NIH Guide for Grants and Contracts
Notice NOT-DK-20-006 from the NIH Guide for Grants and Contracts
Notice NOT-DK-20-008 from the NIH Guide for Grants and Contracts
Notice NOT-AG-20-007 from the NIH Guide for Grants and Contracts